H35.719 Central serous chorioretinopathy, unspecified eye

Name of the Condition

• Central serous chorioretinopathy, unspecified eye

Summary

Central serous chorioretinopathy is a condition characterized by fluid accumulation beneath the retina, typically in the macula, leading to temporary vision changes. It occurs when the retinal pigment epithelium (RPE) allows fluid to leak into the subretinal space, disrupting normal retinal function. This code applies when the affected eye is not specified.

Causes

The exact cause is not fully understood, but it may involve dysfunction of the RPE, which regulates fluid balance in the retina. Stress, corticosteroid use, or hormonal changes are thought to contribute to RPE disruption, allowing fluid leakage from the choroid into the subretinal space.

Risk Factors

• Male gender, particularly ages 20–50.
• Chronic stress or type A personality traits.
• Use of corticosteroids (oral, inhaled, or topical).
• Pregnancy or recent childbirth.
• Systemic conditions like hypertension or autoimmune disorders.

Symptoms

• Blurred or distorted central vision.
• Reduced visual acuity or difficulty reading.
• Perceived size changes of objects (micropsia or macropsia).
• Central scotoma (blind spot) or dimmed vision.
• Mild color vision impairment.

Diagnosis

Diagnosis requires a comprehensive eye exam, including dilated fundus evaluation to detect subretinal fluid. Optical coherence tomography (OCT) confirms fluid accumulation and assesses retinal thickness. Fluorescein angiography may identify leakage points.

Treatment Options

• Observation for mild or self-resolving cases.
• Laser photocoagulation for persistent leakage.
• Photodynamic therapy (PDT) for chronic or recurrent cases.
• Avoidance of corticosteroids if possible.
• Stress management or lifestyle modifications.

Prognosis and Follow-Up

Most cases resolve spontaneously within 3–6 months with good visual recovery. Chronic or recurrent cases may lead to permanent vision changes. Follow-up includes regular eye exams to monitor for recurrence or complications.

Complications

• Permanent vision loss if fluid persists.
• Recurrence of the condition.
• Choroidal neovascularization (rare).
• Retinal pigment epithelial changes.

Lifestyle & Prevention

• Manage stress through relaxation techniques or counseling.
• Avoid corticosteroid use unless medically necessary.
• Maintain a healthy lifestyle with balanced diet and exercise.
• Monitor vision changes and report new symptoms promptly.

When to Seek Professional Help

Seek immediate care if vision worsens suddenly, new blind spots appear, or symptoms persist beyond 3 months. Prompt evaluation is important to rule out other retinal conditions.

Tips for Medical Coders

Use this code when the eye affected by central serous chorioretinopathy is not specified. Document the absence of eye specification or use this code when the condition is bilateral or the eye is unknown. Ensure clinical documentation supports the diagnosis and absence of eye specification.